Report Detail
Global Gene Knockdown Market Size, Status and Forecast 2019-2025
- RnM3356620 |
- 24 June, 2019 |
- Global |
- 105 Pages |
- QYResearch |
- Service & Software
In 2018, the global Gene Knockdown market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Gene Knockdown status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Knockdown development in United States, Europe and China.
The key players covered in this study
Santa Cruz Biotechnology (US)
OriGene (US)
Sigma-Aldrich (US)
Abnova (Taiwan)
Agilent Technologies (US)
Bio-Rad (US)
Cell Signaling Technology (US)
GeneCopoeia (US)
siTOOLs Biotech (Germany)
Novus Biologicals (US)
EMD Millipore (US)
BioVision (US)
Creative Biomart (US)
Selleck Chemicals (US)
MyBioSource (US)
Invitrogen (US)
Qiagen (Germany)
Market segment by Type, the product can be split into
siRNA
shRNA
Other
Market segment by Application, split into
Medical
Bioengineering
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Gene Knockdown status, future forecast, growth opportunity, key market and key players.
To present the Gene Knockdown development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Gene Knockdown are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Gene Knockdown Market Size Growth Rate by Type (2014-2025)
- 1.4.2 siRNA
- 1.4.3 shRNA
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Gene Knockdown Market Share by Application (2014-2025)
- 1.5.2 Medical
- 1.5.3 Bioengineering
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Gene Knockdown Market Size
- 2.2 Gene Knockdown Growth Trends by Regions
- 2.2.1 Gene Knockdown Market Size by Regions (2014-2025)
- 2.2.2 Gene Knockdown Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Gene Knockdown Market Size by Manufacturers
- 3.1.1 Global Gene Knockdown Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Gene Knockdown Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Gene Knockdown Market Concentration Ratio (CR5 and HHI)
- 3.2 Gene Knockdown Key Players Head office and Area Served
- 3.3 Key Players Gene Knockdown Product/Solution/Service
- 3.4 Date of Enter into Gene Knockdown Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Gene Knockdown Market Size by Type (2014-2019)
- 4.2 Global Gene Knockdown Market Size by Application (2014-2019)
5 United States
- 5.1 United States Gene Knockdown Market Size (2014-2019)
- 5.2 Gene Knockdown Key Players in United States
- 5.3 United States Gene Knockdown Market Size by Type
- 5.4 United States Gene Knockdown Market Size by Application
6 Europe
- 6.1 Europe Gene Knockdown Market Size (2014-2019)
- 6.2 Gene Knockdown Key Players in Europe
- 6.3 Europe Gene Knockdown Market Size by Type
- 6.4 Europe Gene Knockdown Market Size by Application
7 China
- 7.1 China Gene Knockdown Market Size (2014-2019)
- 7.2 Gene Knockdown Key Players in China
- 7.3 China Gene Knockdown Market Size by Type
- 7.4 China Gene Knockdown Market Size by Application
8 Japan
- 8.1 Japan Gene Knockdown Market Size (2014-2019)
- 8.2 Gene Knockdown Key Players in Japan
- 8.3 Japan Gene Knockdown Market Size by Type
- 8.4 Japan Gene Knockdown Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Gene Knockdown Market Size (2014-2019)
- 9.2 Gene Knockdown Key Players in Southeast Asia
- 9.3 Southeast Asia Gene Knockdown Market Size by Type
- 9.4 Southeast Asia Gene Knockdown Market Size by Application
10 India
- 10.1 India Gene Knockdown Market Size (2014-2019)
- 10.2 Gene Knockdown Key Players in India
- 10.3 India Gene Knockdown Market Size by Type
- 10.4 India Gene Knockdown Market Size by Application
11 Central & South America
- 11.1 Central & South America Gene Knockdown Market Size (2014-2019)
- 11.2 Gene Knockdown Key Players in Central & South America
- 11.3 Central & South America Gene Knockdown Market Size by Type
- 11.4 Central & South America Gene Knockdown Market Size by Application
12 International Players Profiles
- 12.1 Santa Cruz Biotechnology (US)
- 12.1.1 Santa Cruz Biotechnology (US) Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Gene Knockdown Introduction
- 12.1.4 Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2014-2019)
- 12.1.5 Santa Cruz Biotechnology (US) Recent Development
- 12.2 OriGene (US)
- 12.2.1 OriGene (US) Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Gene Knockdown Introduction
- 12.2.4 OriGene (US) Revenue in Gene Knockdown Business (2014-2019)
- 12.2.5 OriGene (US) Recent Development
- 12.3 Sigma-Aldrich (US)
- 12.3.1 Sigma-Aldrich (US) Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Gene Knockdown Introduction
- 12.3.4 Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2014-2019)
- 12.3.5 Sigma-Aldrich (US) Recent Development
- 12.4 Abnova (Taiwan)
- 12.4.1 Abnova (Taiwan) Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Gene Knockdown Introduction
- 12.4.4 Abnova (Taiwan) Revenue in Gene Knockdown Business (2014-2019)
- 12.4.5 Abnova (Taiwan) Recent Development
- 12.5 Agilent Technologies (US)
- 12.5.1 Agilent Technologies (US) Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Gene Knockdown Introduction
- 12.5.4 Agilent Technologies (US) Revenue in Gene Knockdown Business (2014-2019)
- 12.5.5 Agilent Technologies (US) Recent Development
- 12.6 Bio-Rad (US)
- 12.6.1 Bio-Rad (US) Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Gene Knockdown Introduction
- 12.6.4 Bio-Rad (US) Revenue in Gene Knockdown Business (2014-2019)
- 12.6.5 Bio-Rad (US) Recent Development
- 12.7 Cell Signaling Technology (US)
- 12.7.1 Cell Signaling Technology (US) Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Gene Knockdown Introduction
- 12.7.4 Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2014-2019)
- 12.7.5 Cell Signaling Technology (US) Recent Development
- 12.8 GeneCopoeia (US)
- 12.8.1 GeneCopoeia (US) Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Gene Knockdown Introduction
- 12.8.4 GeneCopoeia (US) Revenue in Gene Knockdown Business (2014-2019)
- 12.8.5 GeneCopoeia (US) Recent Development
- 12.9 siTOOLs Biotech (Germany)
- 12.9.1 siTOOLs Biotech (Germany) Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Gene Knockdown Introduction
- 12.9.4 siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2014-2019)
- 12.9.5 siTOOLs Biotech (Germany) Recent Development
- 12.10 Novus Biologicals (US)
- 12.10.1 Novus Biologicals (US) Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Gene Knockdown Introduction
- 12.10.4 Novus Biologicals (US) Revenue in Gene Knockdown Business (2014-2019)
- 12.10.5 Novus Biologicals (US) Recent Development
- 12.11 EMD Millipore (US)
- 12.12 BioVision (US)
- 12.13 Creative Biomart (US)
- 12.14 Selleck Chemicals (US)
- 12.15 MyBioSource (US)
- 12.16 Invitrogen (US)
- 12.17 Qiagen (Germany)
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Gene Knockdown Market Size, Status and Forecast 2019-2025. Industry analysis & Market Report on Gene Knockdown Market Size, Status and Forecast 2019-2025 is a syndicated market report, published as Global Gene Knockdown Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Gene Knockdown Market Size, Status and Forecast 2019-2025 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
